STOCK TITAN
  1. Home
  2. News
  3. PAYS

PaySign Inc - PAYS STOCK NEWS

Welcome to our dedicated news page for PaySign (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on PaySign.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PaySign's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PaySign's position in the market.

News
Paysign to Host First Quarter 2024 Earnings Call
Rhea-AI Summary
Paysign, Inc. (PAYS) will discuss first quarter 2024 earnings, showcasing their prepaid card programs, patient affordability offerings, digital banking services, and payment processing. The earnings call is scheduled for May 7, 2024, at 5:00 p.m. EDT. Financial professionals can register to ask questions before May 3, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3%
Tags
conferences earnings
-
News
Paysign, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results
Rhea-AI Summary
Paysign, Inc. (PAYS) reported strong financial results for the full year 2023 and fourth quarter 2023. Total revenues increased by 24% to $47.3 million for the full year and by 29% to $13.7 million for the fourth quarter. Net income for the full year was $6.5 million, with diluted earnings per share of $0.12, compared to $1.0 million in 2022. Adjusted EBITDA for the full year was $6.7 million, up 21% from the previous year. Paysign experienced growth in plasma revenue, pharma revenue, and pharma patient affordability revenue. The company ended the year with $17.0 million in unrestricted cash and zero debt, repurchasing 394,558 shares of common stock for $1.1 million. Looking ahead to 2024, Paysign anticipates continued growth in all business units, especially in patient affordability solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.34%
Tags
earnings
-
News
Paysign, Inc. to Sponsor the 2024 International Plasma Protein Congress April 16-17
Rhea-AI Summary
Paysign, Inc. (NASDAQ: PAYS) announces sponsorship of the International Plasma Protein Congress in Athens, Greece. The company has been supporting the Plasma Protein Therapeutics Association for over a decade, advocating for quality and safety in plasma collection and patient access.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.27%
Tags
none
News
Paysign, Inc. Reinforces Payment Processing Acumen With New Executive Hire
Rhea-AI Summary
Paysign, Inc. (PAYS) announces Sandy Ortins as the new VP of EFT Services, bringing extensive experience in payment processing. Sandy's background in banking and ACH operations will enhance Paysign's efficiency and growth in transaction volume.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.93%
Tags
none
-
News
Paysign, Inc. to Sponsor the 2024 Gene Therapy for Rare Disorders Conference March 26-29
Rhea-AI Summary
Paysign, Inc. (PAYS) announces their first-time sponsorship of the 7th Annual Gene Therapy for Rare Disorders conference. The conference aims to address challenges in gene therapy for rare disorders, with Paysign focusing on patient affordability solutions. Matthew Turner, President of Patient Affordability at Paysign, highlights the company's commitment to improving access to gene therapy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
none
-
News
Paysign Inc. to Sponsor the 2024 ACCESS USA Conference March 19-21
Rhea-AI Summary
Paysign, Inc. (PAYS) sponsors the 2024 ACCESS USA Conference, showcasing their commitment to patient affordability and access in the pharmaceutical industry. The conference combines three key events focusing on industry trends, regulatory reforms, and ethical considerations, providing a platform for industry leaders to exchange ideas.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Paysign to Host Fourth Quarter and Full Year 2023 Earnings Call
Rhea-AI Summary
Paysign, Inc. (PAYS) will discuss its fourth quarter and full year 2023 earnings on March 26, 2024, offering insights into its prepaid card programs, patient affordability solutions, digital banking services, and payment processing. The earnings call details are provided for participation and registration for financial professionals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.13%
Tags
conferences earnings
-
News
Paysign, Inc. Reports Third Quarter 2023 Financial Results
Rhea-AI Summary
PAYS reported a 17% increase in total revenues to $12.4 million in Q3 2023, with a net income of $1.1 million and diluted income per share of $0.02. The company added 19 net new plasma donation centers and launched three new patient affordability programs during the quarter, leading to a 13% increase in plasma revenue and a 142% increase in pharma patient affordability revenue. The company also repurchased 75,000 shares of common stock for $150 thousand, ending the quarter with $9.9 million of unrestricted cash and zero debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.53%
Tags
earnings
-
News
Paysign to Host Third Quarter 2023 Earnings Call
Rhea-AI Summary
Paysign, Inc. to discuss third quarter 2023 earnings on November 7, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
conferences earnings
News
Paysign, Inc. Reports Second Quarter 2023 Financial Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.57%
Tags
earnings
Stock PAYS logo
PaySign Inc

Nasdaq:PAYS

PAYS Rankings

#3633 Ranked by Market Cap
#3826 Ranked by Stock Gains
N/A Ranked by Dividends

PAYS Stock Data

230.94M
26.84M
38.43%
27.18%
1.77%
Data Processing, Hosting, and Related Services
Information
Link
United States
Henderson

About PAYS

paysign, inc. provides prepaid card products and processing services under the paysign brand for corporate, consumer, and government applications. the company offers various services, including transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through paysign, a proprietary platform. it also develops prepaid card solutions for corporate incentive rewards and corporate expense, per diem and travel payments, healthcare reimbursement payments, pharmaceutical co-pay assistance, donor compensation, and clinical trials; and payroll or general purpose reloadable cards, as well as gift or incentive cards. in addition, the company offers buy and bill programs for patients to purchase directly from physician's office or through an infusion center for physician administered therapies; payment solution for source plasma collection centers; and paysign premier, a demand deposit account debit card, as well as customer service